Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
The announcement of the deal signaled an end to the [...]
What Trump’s New Drug Pricing Deal Means for People With Obesity
The president’s agreement with drug companies involves a range of [...]
Cardiovascular Benefits of Wegovy Extend Beyond Weight Loss, Study Shows
An analysis found that a shrinking waist size was responsible [...]
Costco to Sell Ozempic and Wegovy, Weight-Loss Wonder Drugs
Costco members will pay $499 a month out of pocket, [...]
Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser
Regulators sent about 100 warning letters this week to drug [...]
Wegovy Gets F.D.A. Approval for MASH
Wegovy has been approved for use among the growing number [...]
How Ozempic Maker Novo Nordisk Lost Its Shine
The pioneering Danish drugmaker was once the most valuable company [...]
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of [...]
WeightWatchers Files for Bankruptcy to Reduce $1 Billion in Debt
The company, which has shaped how millions eat and exercise, [...]
What to Know About Eli Lilly’s Daily Pill for Weight Loss
Eli Lilly reported promising results from a study of its [...]